Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 450

1.
2.

The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.

Yokoi H, Isaji S, Yamagiwa K, Tabata M, Nemoto A, Sakurai H, Usui M, Uemoto S.

J Hepatobiliary Pancreat Surg. 2006;13(2):123-30.

PMID:
16547673
3.

Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.

Jiang L, Liao A, Wen T, Yan L, Li B, Yang J.

Transpl Int. 2014 Jun;27(6):562-9. doi: 10.1111/tri.12297. Epub 2014 Apr 2.

4.

Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.

Ninomiya M, Shirabe K, Facciuto ME, Schwartz ME, Florman SS, Yoshizumi T, Harimoto N, Ikegami T, Uchiyama H, Maehara Y.

J Am Coll Surg. 2015 Mar;220(3):297-304.e3. doi: 10.1016/j.jamcollsurg.2014.12.009. Epub 2014 Dec 13.

PMID:
25617912
5.

Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.

Choi HJ, Kim DG, Na GH, Han JH, Hong TH, You YK.

World J Gastroenterol. 2013 Aug 7;19(29):4737-44. doi: 10.3748/wjg.v19.i29.4737.

6.

Role of surgical resection for multiple hepatocellular carcinomas.

Choi SH, Choi GH, Kim SU, Park JY, Joo DJ, Ju MK, Kim MS, Choi JS, Han KH, Kim SI.

World J Gastroenterol. 2013 Jan 21;19(3):366-74. doi: 10.3748/wjg.v19.i3.366.

7.

Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma.

Abe T, Tashiro H, Teraoka Y, Hattori M, Tanimine N, Kuroda S, Tahara H, Ohira M, Tanaka Y, Kobayashi T, Ide K, Ishiyama K, Ohdan H.

Dig Surg. 2016;33(1):8-14. doi: 10.1159/000441397. Epub 2015 Nov 10.

PMID:
26551258
8.

Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.

Harimoto N, Yoshida Y, Kurihara T, Takeishi K, Itoh S, Harada N, Tsujita E, Yamashita YI, Uchiyama H, Soejima Y, Ikegami T, Yoshizumi T, Kawanaka H, Ikeda T, Shirabe K, Saeki H, Oki E, Kimura Y, Maehara Y.

Transplant Proc. 2015 Apr;47(3):703-4. doi: 10.1016/j.transproceed.2014.09.178. Epub 2015 Mar 27.

PMID:
25819732
9.

Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.

Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, Harada N, Yamashita Y, Sugimachi K, Kayashima H, Iguchi T, Maehara Y.

Transplantation. 2009 Feb 27;87(4):531-7. doi: 10.1097/TP.0b013e3181943bee.

PMID:
19307789
10.

Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection.

Li C, Zhu WJ, Wen TF, Dai Y, Yan LN, Li B, Yang JY, Wang WT, Xu MQ.

J Gastrointest Surg. 2014 Aug;18(8):1469-76. doi: 10.1007/s11605-014-2550-0. Epub 2014 Jun 6.

PMID:
24903846
11.

Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.

Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D'Onofrio M, Iacono C.

J Gastrointest Surg. 2012 Feb;16(2):301-11; discussion 311. doi: 10.1007/s11605-011-1745-x. Epub 2011 Nov 18.

PMID:
22095524
12.

Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies.

Lei J, Yan L.

J Gastrointest Surg. 2012 Nov;16(11):2120-5. doi: 10.1007/s11605-012-2019-y. Epub 2012 Sep 5.

PMID:
22948843
13.

Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.

Yeh CN, Chen MF, Lee WC, Jeng LB.

J Surg Oncol. 2002 Dec;81(4):195-202. Review.

PMID:
12451624
14.

Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.

Xiao GQ, Song JL, Shen S, Yang JY, Yan LN.

World J Gastroenterol. 2014 Aug 21;20(31):10953-9. doi: 10.3748/wjg.v20.i31.10953.

15.

Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.

Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS.

Transplantation. 2014 Jan 15;97(1):71-7. doi: 10.1097/TP.0b013e3182a68953.

PMID:
24056623
16.

Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis.

Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, D'Onofrio M, Martone E, Nicoli P, Iacono C.

J Gastrointest Surg. 2008 Jan;12(1):192-8. Epub 2007 Nov 13.

PMID:
17999123
17.

Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.

Taura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, Seo S, Machimoto T, Uemoto S.

Surgery. 2007 Nov;142(5):685-94.

PMID:
17981188
18.

Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria.

Chua TC, Saxena A, Chu F, Morris DL.

Am J Clin Oncol. 2012 Apr;35(2):141-5. doi: 10.1097/COC.0b013e318209ab7d.

PMID:
21336092
20.

Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.

Harimoto N, Shirabe K, Nakagawara H, Toshima T, Yamashita Y, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y.

Transplantation. 2013 Dec 15;96(11):1008-12. doi: 10.1097/TP.0b013e3182a53f2b.

PMID:
24113512

Supplemental Content

Support Center